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Abstract
Dystonia represents the third most common movement disorder in humans. At least 15 genetic loci (DYT1-15) have been
identified and some of these genes have been cloned. TOR1A (formally DYT1), the gene responsible for the most common
primary hereditary dystonia, encodes torsinA, an AAA ATPase family protein. However, the function of torsinA has yet to be
fully understood. Here, we have generated and characterized a complete loss-of-function mutant for dtorsin, the only
Drosophila ortholog of TOR1A. Null mutation of the X-linked dtorsin was semi-lethal with most male flies dying by the pre-
pupal stage and the few surviving adults being sterile and slow moving, with reduced cuticle pigmentation and thin, short
bristles. Third instar male larvae exhibited locomotion defects that were rescued by feeding dopamine. Moreover,
biochemical analysis revealed that the brains of third instar larvae and adults heterozygous for the loss-of-function dtorsin
mutation had significantly reduced dopamine levels. The dtorsin mutant showed a very strong genetic interaction with Pu
(Punch: GTP cyclohydrolase), the ortholog of the human gene underlying DYT14 dystonia. Biochemical analyses revealed a
severe reduction of GTP cyclohydrolase protein and activity, suggesting that dtorsin plays a novel role in dopamine
metabolism as a positive-regulator of GTP cyclohydrolase protein. This dtorsin mutant line will be valuable for
understanding this relationship and potentially other novel torsin functions that could play a role in human dystonia.
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Introduction
Dystonia is a movement disorder characterized by sustained
muscle contraction. While 15 different gene loci have been
implicated in primary hereditary dystonia (DYT1-DYT15) [1], the
most common and severe form, early-onset dystonia (also known
as DYT1 dystonia) is due to mutation in TOR1A (formerly DYT1)
and displays dominant inheritance with reduced penetrance [2].
TOR1A encodes torsinA, a 332 amino acid protein from the AAA
ATPase family. TorsinA is localized in the lumen of the
endoplasmic reticulum and the nuclear envelope [2], but its
function is not fully understood. Most cases of DYT1 dystonia are
caused by a single mutation, a 3 bp (GAG) deletion that results in
the loss of a glutamic acid residue in the carboxyl terminal region
of torsinA [3].
In mammals, four paralogous torsin genes (TOR1A, TOR1B,
TOR2A, and TOR3A) have been described, while Drosophila
melanogaster has only a single torsin gene, dtorsin (previously known
as torp4a: CG3024) in 4C11 on the X chromosome [4]. The dtorsin-
encoded protein, Dtorsin, comprises 339 amino acids with 31.9%
identity to human torsinA and also displays the characteristic
features of the AAA ATPase gene family [5]. Misexpression in
Drosophila of the mutant form of human torsinA, pan-neuronally or
in monoaminergic cells results in a locomotor defect [6] and
aberrant bouton morphologies at synapses [7], though the function
of Dtorsin is unclear. Muraro and Moffat [8] have reported that
targeted down-regulation of the dtorsin gene in the Drosophila eye
caused progressive degeneration of the retina, but no loss-of-
function mutants of dtorsin have previously been characterized.
To investigate the function of dtorsin, we generated loss-of-
function mutant fly lines by the ‘ends-out’ gene targeting method
in which homologous recombination at the ends of the gene results
in the exchange of the entire targeted genomic sequence with a
heterologous sequence [9,10]. By replacing the dtorsin gene with
unrelated sequence from the white+ gene, we created a complete
deletion of the dtorsin gene in the genome.
Mutant flies showed the following phenotypes: 1) the vast
majority of mutant males died by the pre-pupal stage; 2) the few
surviving adult males were sterile with reduced pigmentation and
thin, short bristles; 3) the late third instar male larvae exhibited
locomotor deficits. As some of these phenotypes are associated
with mutations that disrupt dopamine metabolism [11,12], we
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explored this pathway in the mutant flies using both biochemical
and genetic approaches. Our findings indicate that disrupted
dopamine metabolism is at least one consequence of this null
mutation and that dtorsin is a novel positive-regulator of GTPCH
protein in Drosophila.
Results
Generation of dtorsin loss-of-function mutants by
homologous recombination
To investigate the function of dtorsin, we generated a loss-of-
function mutation using ‘ends-out’ gene targeting designed to
remove almost the entire coding sequence [9,10] (Figure S1A and
Materials and Methods). We screened approximately 40,000 flies
and obtained fourteen lines that had a white+ (w+) insertion on the
X chromosome. Seven of the fourteen were semi-lethal lines, in
which only a few adult males survived. PCR analysis with dtorsin
gene-specific primers demonstrated that males from each of the
seven semi-lethal lines lacked the dtorsin gene, while males of the
seven viable lines retained the dtorsin gene (data not shown). The
targeted homologous recombination event was expected to yield
the same genomic structure in all correctly targeted lines. To
confirm this, we performed Southern blot analysis on two semi-
lethal lines, each derived from a different donor line (y w
dtorsinKO13/Y males from B2-1 and w dtorsinKO78/Y males from
B7-1; see Materials and Methods). The results were consistent with
precise homologous recombination and replacement of the dtorsin
gene with the targeting construct (Figure S1B). The integrity of the
junctions was confirmed by sequencing of the PCR products. Both
dtorsinKO13 and dtorsinKO78 lack all dtorsin sequence from the
translation initiator ATG to 16 bases upstream of the termination
codon (data not shown), leaving no potential to produce Dtorsin
protein in these lines. Anti-Dtorsin antibody revealed a 38 kDa
protein band, the predicted molecular weight of the Dtorsin
protein, in wild type adult whole body extracts and head extracts
(Figure S2 lanes 1 and 3), the corresponding dtorsinKO13/Y male
mutant extracts showed no clear band of 38 kDa protein (Figure
S2 lanes 2 and 4). The semi-lethality of all seven correctly targeted
lines was rescued by introducing a 1.9 kb genomic fragment that
contained the entire dtorsin gene (Table S1). These results indicate
that all seven semi-lethal lines were dtorsin loss-of-function mutants.
Adult phenotype of the dtorsin mutants
All seven mutant lines had identical phenotypes. They were
recessive semi-lethal lines with only a few males reaching
adulthood. As these males were sterile, it was not possible to
generate homozygous mutant females. To determine the stage of
male lethality, we made a dtorsinKO13 line carrying the FM7i ActGFP
X-chromosome balancer. Hemizygous dtorsin mutant male first
instar larvae were identified by their GFP-negative phenotype.
Most of these animals developed to late third instar larvae, and
died at the pre-pupal stage. Some mutants entered pupation but
failed to eclose. In isolated cultures of hemizygous dtorsin-null
larvae, about 10% of these developed to the adult stage, while 94%
of wild type (y w) larvae developed to the adult stage when
maintained under the same conditions. In mixed cultures where
larvae of both genotypes were present, very few dtorsin null males
developed to the adult stage (Table S1). The few surviving male
adults showed the following characteristic phenotypes. The body
color appeared paler than wild type, which suggested reduced
pigmentation of the cuticle (Figure 1A, B, C, and D). The flies had
thin, short bristles (Figure S3A and B), moved slowly, and, as noted
above, were sterile. All of these phenotypes were rescued by
introducing the 1.9 kb genomic fragment that contained the
Figure 1. dtorsin loss-of-function mutant flies exhibit pigmentation phenotypes. A–D, Pigmentation phenotype of dtorsin mutants. Adult
males of the genotype y w/Y (A), y w dtorsinKO13/Y (B), Oregon R (C), and w dtorsinKO78/Y (D) flies. The pictures for A–D were taken one day after
eclosion to ensure pigmentation reached the maximum level. Since dtorsinKO78 male has y+ genotype, it was compared to the Oregon R, which is also
y+.
doi:10.1371/journal.pone.0026183.g001
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coding region of the dtorsin gene (Table S1 and Figure S3C). UAS-
dtorsin cDNA driven by the Actin5c- or the Tubulin-GAL4 driver
also rescued all phenotypes (Table S1).
Mutant third instar larvae show a locomotion deficit
The surviving mutant adult flies moved slowly, compared to
wild type. Since most of the mutants died at the pre-pupal stage,
we studied the movements of the mutants as larvae prior to this
stage. Drosophila larval crawling entails repeated, rhythmic,
peristaltic contraction. During each peristaltic stride, muscle
contractions are propagated from one end of the body to the
other, passing through all eleven segments, one at a time [13]. Late
third instar larval locomotion has been established in several
recent studies as an excellent system to study the regulation of
locomotion and has been used to evaluate various parameters of
larval movement [13,14,15,16,17] and to examine the effects of
various mutants on locomotion [13,15,16,17,18].
To quantify the difference in locomotion between wild type and
mutant larvae, we analyzed peristaltic frequency [13] allowing
third instar male larvae to crawl freely on an agarose substrate in
the absence of any obvious sensory cues for a period of 60 seconds.
The entire period was recorded under high magnification with a
camera video program. Whereas wild type (y w) male larvae
moved at 53.362.1 strides per minute (n = 33), dtorsinKO13 male
larvae exhibited approximately a ,50% decrease in stride
frequency, 24.663.0 (n = 29, p,0.0001) (Figure 2A, and Video
S1 and S2). The locomotion deficit in mutant male third instar
larvae was fully rescued (61.861.4, n = 21) by introducing the
genomic DNA fragment containing the entire dtorsin gene
(Figure 2A).
Next we examined the crawling pattern of the larvae. To
visualize the locomotion of larvae, the videos were analyzed with a
newly developed program ‘‘Prairie Dog’’. Wild type male larvae
moved in a relatively straight line, with few changes in direction
until they quickly reached the edge of the dish (Figure 2B, C).
However, mutant male larvae frequently stopped and changed
direction. As a result, mutant larvae often circled around the same
location, gaining little distance from the starting point (Figure
2D, E).
Neural expression of dtorsin can rescue the larval
locomotion deficit
To determine whether the larval mobility deficit was specifically
due to lack of Dtorsin in neurons, we used the GAL4/UAS system
[19] to express a dtorsin cDNA using neuronal drivers (Figure 3).
When the pan-neuronal driver elavGAL4 was combined with the
UAS-dtorsin cDNA transgene, a strong rescue of the larval mobility
was observed (50.562.5, n = 14, p,0.0001) compared to the
equivalent dtorsin-null male larvae (elavGAL4, dtorsinKO13) lacking
the UAS-dtorsin transgene (28.361.4 strides/min, n = 32). With the
dopaminergic tissue-specific driver TH-GAL4 and the UAS-dtorsin
transgene, we observed a significant increase of peristaltic
frequency (39.462.4, n = 12, p = 0.0003) compared to the control
(y w dtorsinKO13), although the rescue was weaker than that achieved
with elavGAL4, suggesting that other neurons in addition to
dopaminergic neurons may play important roles in regulating
larval mobility in dtorsin null mutants. Transgenes of elavGAL4 or
TH-GAL4 alone had no effect on the mobility of larvae with or
without the dtorsinKO13 null mutation (Figure 3). Expression of the
dtorsin cDNA controlled by a muscle-specific driver, MHC-GAL4
[20] did not rescue the dtorsin null mutant larval mobility defect
(data not shown). These results suggested that dtorsin expression in
neurons plays an important role in regulating larval mobility.
Rescue of larval locomotion deficit by neuronal
expression of human torsinA
Next, we examined if the wild type human torsinA cDNA could
rescue the dtorsin null mutant mobility defect. We found that
human torsinA cDNA expressed with the Actin5c- or the Tubulin-
GAL4 drivers rescued all phenotypes (pigmentation, bristle, and
mobility) at very low frequency (Table S1). When this same human
torsinA was expressed with the neuron-specific driver elavGAL4, a
very significant rescue of the 3rd instar dtorsin null male larval
mobility was observed (56.363.8 strides/min, n = 14, p,0.0001)
compared to the control dtorsin null male larvae (28.361.4 strides/
min, n = 32) (Figure 3). The peristaltic frequency of the dtorsin null
male larvae that expressed the human torsinA cDNA in neurons
was statistically similar to the wild type control (y w; 55.262.5
strides/min, n = 15). These data indicate that the neuronal
functions of the human torsinA and dtorsin are very well conserved
with respect to the regulation of the larval locomotion.
Dopamine restored locomotor deficit phenotype in
dtorsin mutant lines
In Drosophila, ingestion of dopamine increases dopamine pools in
the fly head, though in mammals peripheral dopamine does not
enter into the brain [21]. Since expression of dtorsin in
dopaminergic cells produced detectable rescue of the locomotion
phenotype, we tested whether addition of dopamine to fly food
could also rescue this defect. Previous studies have shown that
dopamine, serotonin, and octopamine can all affect larval
locomotion as well as adult behaviors in Drosophila [16,22,23].
Consequently, we also tested whether serotonin or octopamine
could rescue the locomotion deficit of male dtorsin null larvae.
Adding 20 mM dopamine in the food during the larval stage
significantly increased the stride frequency of male dtorsinKO13
mutant larvae (43.663.2, n = 15, p,0.0001) compared to that of
the dtorsinKO13 larvae grown without drug supplementation
(22.962.5, n = 28). However, no significant changes were detected
in the mutant larvae grown with 20 mM octopamine (26.763.6,
n = 10, p = 0.4240) or 10 mM serotonin (24.063.9, n = 13,
p = 0.8148) supplementation. No significant differences were
observed between wild type larvae after supplementation with
dopamine (53.362.4, n = 10, p = 0.6135), octopamine (51.663.6,
n = 8, p = 0.4028), or serotonin (47.462.8, n = 9, p = 0.0562) and
those grown without monoamine supplementation (55.262.5,
n = 15) (Figure 4).
After dopamine ingestion, the dtorsinKO13 male mutant larvae
also exhibited relatively straight crawling patterns, similar to those
of the wild type larvae with or without dopamine (Figure 5). The
reduced cuticular pigmentation phenotype of surviving male
adults was also partially rescued by dopamine supplementation
(Figure S4).
Dopamine level is significantly reduced in dtorsin mutant
heterozygotes
In Drosophila, dopamine metabolism has a fundamental role in
pigmentation of the cuticle [11,12], and in many neurologically-
mediated processes, including locomotion [24]. Consequently, as
the reduced pigmentation and the locomotion deficits in the dtorsin
mutants and their rescue by ingestion of dopamine suggested that
dopamine metabolism must be disturbed by the dtorsin mutation,
we measured dopamine levels in the third instar larval brain and
adult heads. Since large numbers of adults or larvae were required
for the analyses of dopamine by HPLC (see Materials and
Methods), we used heterozygous mutants for these experiments.
Wild type (y w) female larvae contained 0.063160.0025 ng
dtorsin, a New Regulator of Dopamine Metabolism
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dopamine/brain (n = 3, 75 brains per assay), whereas dtorsin
heterozygous female larvae (dtorsinKO78/+) had 0.034060.0014 ng
dopamine/brain (n = 3) corresponding to a 46% reduction
(p,0.001) (Figure 6A). Dopamine pools in the heads of adult
female heterozygotes were even more dramatically altered, with
dopamine levels reduced from 0.33 ng/head in the y w control flies
Figure 2. dtorsin mutant larvae have mobility defects. A. dtorsin mutants have reduced larval mobility. Peristaltic frequencies were counted
manually during the wandering stage of third instar larvae of the genotype y w (n = 33), y w dtorsinKO13/Y (n = 29), and y w dtorsinKO13/Y; GDT101-2
(n = 21). Results are the mean 6 S.E.M. ** p,0.0001, very significant difference between the wild type and the dtorsin mutant. B–E. Representative
crawling patterns of the wild type (B, C) and the dtorsin mutant male (D, E) larvae. Locations of larval heads (blue line) and tails (red line) were
captured by video recording for 60 seconds and visualized by the Prairie Dog software. Tracking of larval movement was stopped when the larva
reached the edge of the plate. The genotypes of larvae were y w (B, C) and y w dtorsinKO13/Y (D, E). Most of the wild type larvae reached the edge of
the dish within 30–40 seconds when they started from the center of the dish (B, C). Many of the dtorsin mutant male larvae circled around the same
location without much net distance gain from the starting point (D, E). The numbers on x- and y- axes are arbitrary numbers indicating x- and y-
coordinates to define locations of the larval head and tail.
doi:10.1371/journal.pone.0026183.g002
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Figure 3. Rescue of dtorsin mutant male larvae mobility defects by cDNA expression. Peristaltic frequencies were counted for the
wandering stage third instar larvae of the genotype wild type y w/Y male (n = 15), w elavGAL4/Y (n = 9), y w/Y; TH-GAL4(III) (n = 12), w elavGAL4
dtorsinKO13/Y (n = 32), w elavGAL4 dtorsinKO13/Y; UAS-dtorsinB5(II)/+ (n = 20), w elavGAL4 dtorsinKO13/Y; UAS-htorA#8(II)/+ (n = 20), y w dtorsinKO13/Y
(n = 28), and y w dtorsinKO13/Y; TH-GAL4(III)/+; UAS-dtorsinB5(II)/+ (n = 12). Results are mean 6 S.E.M. *** p,0.0001, very significant difference between
the dtorsin mutant male (w elavGAL4 dtorsinKO13/Y) and the dtorsin mutant male with elavGAL4/UAS-dtorsin. *** p,0.0001, very significant difference
between the dtorsin mutant male (w elavGAL4 dtorsinKO13/Y) and the dtorsin mutant male with elavGAL4/UAS-htorA. ** p,0.001, significant
difference between the dtorsin mutant (y w dtorsinKO13/Y) and the dtorsin mutant male with TH-GAL4/UAS-dtorsin.
doi:10.1371/journal.pone.0026183.g003
Figure 4. Rescue of dtorsin mutant larvae mobility defects by dopamine feeding. Peristaltic frequencies were counted for the wandering
stage third instar larvae of the genotype wild type (y w) (n = 15), wild type (y w) (+20 mM dopamine) (n = 10), wild type (y w) (+20 mM octopamine)
(n = 8), wild type (y w) (+10 mM serotonin) (n = 9), y w dtorsinKO13/Y (n = 28), y w dtorsinKO13/Y (+20 mM dopamine) (n = 15), y w dtorsinKO13/Y (+20 mM
octopamine) (n = 10), and y w dtorsinKO13/Y (+10 mM serotonin) (n = 13). Results are mean 6 S.E.M. *** p,0.0001, very significant difference between
the dtorsin mutant with no drug supplementation and the dtorsin mutant with 20 mM dopamine supplementation. There was no significant
difference between the dtorsin mutant males with no drug supplementation and the dtorsin mutant males with 20 mM octopamine (p = 0.4240) or
the dtorsin mutant male with 10 mM serotonin (p = 0.8148). There was no significant difference between the wild type with no drug supplementation
and the wild type with drug (+20 mM dopamine, +20 mM octopamine, or +10 mM serotonin).
doi:10.1371/journal.pone.0026183.g004
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to approximately 0.10 ng/head in two different dtorsin mutants
(dtorsinKO13/+ : 0.1160.02 ng/head, n = 3, p,0.001; dtorsinKO78/+
: 0.1260.04 ng/head, n = 3, p,0.001) (Figure 6B).
We next sought to determine whether trafficking of dopamine
was affected by the dtorsin mutation. Turnover of dopamine during
synaptic release can be inferred by the levels of the dopamine
metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) and by the
ratio of DOPAC to dopamine in flies, as in mammals [21,25].
Although the levels of DOPAC in the dtorsin heterozygous mutant
were decreased, the reduction was clearly not proportional to the
reduction in dopamine levels. In consequence, the resulting
DOPAC:dopamine ratios were elevated over two-fold (Figure 6C,
D). These neurochemical data suggested that the reduction of
dtorsin in dopaminergic cells may lead to depressed synthesis of
dopamine as well as trafficking abnormalities. Alternatively, the
loss of dtorsin might lead to loss of dopaminergic cells.
Tyrosine hydroxylase (TH) catalyses the first and rate-limiting
step in the dopamine biosynthesis pathway and is expressed in all
dopaminergic neurons. Therefore, we next examined third instar
larval brain using anti-dTH antibody to determine whether
Drosophila TH (dTH) is expressed in dopaminergic neurons in the
brains of dtorsin null mutants [26]. The dopaminergic cell pattern
has been well characterized in the central nervous system of
Drosophila larvae and consists of four clusters of 4–10 neurons in
each brain hemisphere and a stereotyped pattern of three to five
paired or unpaired neurons per segment in the ventral ganglion
[27] (Figure 7A). We found that dTH was expressed in the brains
of hemizygous dtorsinKO13 third instar larvae and that the number
of dTH-positive cell bodies was approximately normal and clearly
not sufficiently reduced to account for the dramatic loss of
dopamine observed. However, we did observe some apparent
morphological changes in the positioning of cell bodies of dTH-
positive neurons and in the patterning of dTH-positive axons in
the central brain region of the hemizygous dtorsin null male larvae
(Figure 7B). Further studies are underway to understand the exact
nature of these structural differences between the wild type and the
dtorsin null mutant brains, but we are able to conclude that loss of
Dtorsin expression and the consequent reduction in dopamine
levels are not associated with failure of dopaminergic neurons to
differentiate or their subsequent degeneration.
Genetic interactions of dtorsin with Pu (Punch) or ple
(pale)
Dopamine synthesis is directly regulated by the specific activity
of TH, which, in turn, is modulated by the amount of its cofactor,
tetrahydropterin (BH4). In consequence, TH activity is regulated
indirectly by the activity of the rate-limiting enzyme in BH4
synthesis, GTP cyclohydrolase (GTPCH) in flies, as in mammals
[28,29]. We addressed the hypothesis that dopamine synthesis is
affected by mutations in dtorsin and further pursued a putative role
in dopamine trafficking by first conducting gene interaction
analysies. We tested for genetic interaction of the null dtorsinKO13
allele with mutant alleles of ple (pale), which encodes TH [30,31],
Pu (Punch), the Drosophila ortholog of GTP cyclohydrolase
(GTPCH) [32], and DAT, encoding the dopamine transporter
[33]. Pu and ple loss-of-function mutants show similar phenotypes
to each other [34], as Pu mutants exhibit reductions in dopamine
pools due to limiting BH4 levels [35]. Homozygous Pu loss-of-
function mutants die during late embryogenesis with completely
unpigmented and weak cuticles [32]. The human orthologs of
these two genes underlie DYT5 and DYT14 (Dopa-responsive)
dystonia [1] which is phenotypically similar to DYT1 dystonia,
except that DYT5 and DYT14 patients respond very well to the
administration of L-dopa [36,37] whereas DYT1 patients do not.
Most DYT14 patients have dominantly inherited loss of function
mutations in the GCH1 gene, while mutations in the TH gene are
responsible for a rare recessive form [36]. The third gene involved
in dopamine metabolism, DAT, was found to be mutated in a
hyperactive fly line, fumin. Elimination of DAT activity in the
DATfumin mutant caused a dramatic increase in the length of the
waking phase [33].
In order to test the possibility of a genetic interaction between
the dtorsin null mutation and loss-of-function mutations of Pu, ple,
or DATfumin, we analyzed the peristaltic stride frequency of the
double-heterozygous female mutant larvae. No phenotype was
seen in any single heterozygous mutant line. The stride frequencies
of PuZ22/+ males (48.762.0, n = 20) and females (46.861.9,
n = 23) were statistically similar to the stride frequency of the
dtorsinKO13/+ females (48.961.6, n = 22). However, the double
heterozygous dtorsinKO13/+; PuZ22/+ females showed very signifi-
cantly reduced peristaltic frequency (28.861.4, n = 30, p,0.0001),
relative to either single heterozygote (Figure 8A). While
dtorsinKO13/Y male third instar larvae were mostly viable, very
few dtorsinKO13/Y; PuZ22/+ male of the third instar larvae were
observed.
There was a much weaker interaction between dtorsin and ple.
While no decreased locomotion phenotype was seen in ple2/+
females (52.461.2, n = 20), dtorsinKO13/+; ple2/+ female larvae
showed a slight but significant reduction of peristalsis frequency
Figure 5. Effect of dopamine on the larval crawling patterns.
Video tracking of the representative crawling patterns of the wild type
(A, B), the wild type with 50 mM dopamine supplementation (C, D), the
y w dtorsinKO13 mutant male (E, F), and the y w dtorsinKO13 mutant male
with 50 mM dopamine supplementation (G, H). Locations of larval
heads (black lines) were tracked by the ICARUS software. Tracking was
stopped when the larva reached the edge.
doi:10.1371/journal.pone.0026183.g005
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(45.862.3, n = 31, p = 0.0007), compared to dtorsinKO13/+; +/+
females (55.561.3, n = 20) (Figure 8B).
No statistically significant interaction was detected between dtorsin
and DATfumin. The double heterozygous mutant dtorsinKO13/+;
DATfumin/+ females showed similar peristaltic frequency (46.161.4,
n = 14, p = 0.5402) compared to single heterozygous mutant dtor-
sinKO13/+ females (47.662.9, n = 7) (Figure S5). The DATfumin mutation
also had no effect on the mobility of dtorsin hemizygous mutant males.
The DATfumin heterozygous mutant dtorsinKO13/Y; DATfumin/+ males
had a peristaltic frequency (21.663.6, n = 12, p = 0.7613) that was
statistically identical to dtorsin mutant dtorsinKO13/Y males (22.962.5,
n = 28).
Thus the dtorsin null mutation showed a very strong genetic
interaction with the Punch (GTPCH) mutation, a weaker
interaction with the ple (TH) mutation, and no detectable
interaction with the fumin (DAT) mutation.
GTPCH, but not TH activity, is severely reduced in dtorsin
heterozygous mutant lines
The above findings suggested that the Dtorsin function may
regulate the Pu gene/GTPCH protein activity. To test this
hypothesis, extracts were prepared from wild type (y w) and dtorsin
heterozygous mutant (y w dtorsinKO13/+ and w dtorsinKO78/+) adult
heads and TH and GTPCH activities were compared (Figure 9).
No significant difference was detected between the TH activities of
the dtorsin null heterozygous flies (y w dtorsinKO13/+ : 1.5360.06
L-dopa nmoles/min/mg protein, n = 3 independent assays,
p = 0.2962; w dtorsinKO78/+ : 1.4560.12 L-dopa nmoles/min/mg
Figure 6. Effect of dtorsin mutation on dopamine in larval brains and adult heads. A. Effect of dtorsin heterozygous mutation on dopamine
pools in larval brains (nanograms per brain). Monoamines were extracted from third instar larval brains and dopamine was separated and quantified
by HPLC. dtorsin mutation significantly reduced dopamine levels. The genotypes of larvae were y w females (n = 3 independent replications) and w
dtorsinKO78/+ females (n = 3 independent replications). Error bars indicate S.E.M. ** p,0.001, significant difference between the wild type and the
dtorsin heterozygous mutant. B.-D. Effect of dtorsin heterozygous mutation on dopamine levels (nanograms per head). (B), DOPAC levels (nanograms
per head) (C), and DOPAC/dopamine ratio (D) in adult heads. The genotypes of adults were y w females (n = 3 independent replications), y w
dtorsinKO13/+ females (n = 3 independent replications), and w dtorsinKO78/+ females (n = 3 independent replications). Error bars indicate S.E.M.
** p,0.001, significant difference in dopamine levels between the wild type and the dtorsin heterozygous mutant females (B). No statistically
significant difference was observed in DOPAC levels between the wild type and the dtorsin heterozygous mutant females, although the mutant levels
were slightly lower (C). * p,0.01, significant difference in DOPAC/dopamine ratio between the wild type females and the dtorsin heterozygous
mutant females (D).
doi:10.1371/journal.pone.0026183.g006
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protein, n = 3 independent assays, p = 0.2657) and the wild type
flies (y w) (1.6260.05 L-dopa nmoles/min/mg protein, n = 3
independent assays). However, a significant reduction in GTPCH
activity was observed in the dtorsin null mutant heterozygous flies
(y w dtorsinKO13/+ : 0.063360.009 neopterin nmoles/min/mg
protein, n = 3 independent assays, p,0.01; w dtorsinKO78/+ :
0.059060.015 neopterin nmoles/min/mg protein, n = 3, p,0.01)
compared to wild type flies (y w) (0.13860.087 neopterin nmoles/
min/mg protein, n = 3 independent assays). These results suggest
that the dtorsin is a novel positive-regulator of GTPCH activity in
Drosophila.
GTPCH protein levels are severely reduced in dtorsin
heterozygous and hemizygous mutant lines
The above findings suggested that dtorsin might be required for
maintaining GTPCH protein levels. To test this hypothesis, we
prepared extracts from heads of wild type adult males (y w), dtorsin
heterozygous adult females (y w dtorsinKO13/+), and dtorsin
hemizygous adult males (y w dtorsinKO13/Y) and compared TH
and GTPCH protein levels by Western blot analysis (Figure 10,
lanes 1–3). No significant difference was detected between the TH
protein levels of dtorsin null hemizygous flies (y w dtorsinKO13),
heterozygous flies (y w dtorsinKO13/+ females), and of wild type flies
(y w) (Figure 10, lanes 4–6). However, a very severe reduction in
the level of GTPCH protein was observed in the dtorsin null
mutant heterozygous females (y w dtorsinKO13/+) compared to wild
type (y w). Moreover, only very low levels of GTPCH protein level
were detected in dtorsin null mutant hemizygous males, suggesting
only a very small amount of GTPCH proteins are present in the
hemizygotes (Figure 10, lanes 1–3). These results support the
conclusion that dtorsin is required for maintaining the level of
GTPCH protein in Drosophila though the molecular mechanism by
which it acts remains to be elucidated.
Discussion
The human genome contains four paralogous genes of the
torsin family, while Drosophila has a single torsin gene, dtorsin,
encoding a protein of the AAA family of adenosine triphosphatases
(ATPases), related to the Clp protease/heat shock family [4]. The
precise functions of these genes and the degree to which their
activities may overlap are not known, though TOR1A is notable for
causing early-onset dystonia due to a codon deletion that removes
a particular glutamic acid residue from the torsinA protein.
TorsinA-null knock-out mice (Tor1a2/2) have been created and
die at birth with abnormal nuclear membrane morphology in
neural cells [38]. In comparison to the human genes, dtorsin is most
closely related to TOR1A [4,39], suggesting that investigation of
the fly protein’s function may be informative concerning the
pathway(s) disrupted in human early onset dystonia. Our
generation and characterization of a null mutant for dtorsin
revealed that it is an essential gene in flies, as mutants typically fail
to reach adulthood and those that do survive fail to reproduce.
Null dtorsin mutant flies display both morphological and behavioral
phenotypes that may provide starting points for elucidating
activities of the Dtorsin protein, using both biochemical and
genetic strategies. Our initial examination of these phenotypes
indicates that at least one major disruption in dtorsin mutant flies
involves regulation of dopamine, a function also implicated in
human dystonia [40]. We expect that the availability of the dtorsin
null mutant will facilitate investigation of this activity and other
effects of torsin deficiency that are likely to emerge with more
detailed study.
We were led to examine dopamine metabolism in the dtorsin
mutants because of the phenotypes exhibited by rare adult
survivors, which had a pale body color and thin bristles (Figure 1
and S3), moved slowly and were sterile. A series of reports have
shown that dopamine not only functions as a neurotransmitter but
also plays a role in cuticle pigmentation, fertility, and other vital
functions in Drosophila [11,12,41]. Thus the most evident
phenotypes exhibited by the dtorsin null mutants are consistent
with previously reported phenotypes caused by dopamine
deficiency.
Disruption of dopamine metabolism in the dtorsin mutants was
supported by HPLC analysis of heterozygous dtorsin mutant
larval and adult brains/heads which demonstrated a signifi-
cantly reduced dopamine level (Figure 6) and by rescue of the
larval locomotion defect and cuticle pigmentation by feeding
dopamine (Figure 4, 5, S4). Thus, dopamine synthesis appears
to be disrupted in dtorsin null flies and is likely to be largely
responsible for both the deficit in larval locomotion and in
cuticle pigmentation. While ingestion of serotonin and octopa-
mine had no significant effect on the dtorsin larval locomotion
deficit, the results of this particular assay do not exclude the
possibility that other monoamine pathways may also be altered
in these flies. Indeed the weaker rescue of the locomotor
phenotype by expression in dopaminergic neurons than by more
widespread neuronal expression (Figure 3) suggests a role for
other neuronal elements/pathways. Further studies, including
the measurement of serotonin and octopamine pools, will be
required to examine the effect of dtorsin null mutation on these
particular pathways.
Our visualization of dopaminergic neurons in mutant flies
indicated that the reduced dopamine levels were not due to
reduced numbers of dopaminergic neurons (Figure 7), suggesting a
relative decrease in dopamine production in the absence of
Dtorsin. Dopamine synthesis involves hydroxylation of the amino
acid L-tyrosine by TH to produce 3,4-dihydroxy-1-phenylalanine
(L-dopa), which is subsequently decarboxylated by aromatic-L-
amino acid decarboxylase to form dopamine. TH activity depends
on the availability of its cofactor, BH4 [32], which is produced by
conversion of GTP to 2,4-dihydroneopterin triphosphate by
GTPCH, followed by reduction and dephosphorylation to the
Figure 7. The third instar larval brains of dtorsin mutants have
TH-positive cells. A and B. Comparison of patterns of TH
immunostaining (in green) in the third instar larval central nervous
system of the wild type male (A) and the dtorsin mutant male (B). A: A
projection of twenty-seven confocal z-sections of wild type (y w) third
instar male brain is shown. B: A projection of thirty confocal z-sections
of y w dtorsinKO13/Y third instar male larval brain is shown. The
projection was made from a series of confocal Z-sections (optical
thickness 2 mm) that covered the whole brain regions using the NIH
Image-J program with the Max intensity method. vg: ventral ganglion.
doi:10.1371/journal.pone.0026183.g007
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final product, BH4, by 6-pyruvoyltetrahydropterin synthase and
sepiapterin reductase, respectively [29].
In flies, TH is encoded by the ple (pale) gene and GTPCH is
produced from the Pu (Punch) gene. Our finding that genetic
interaction of mutations in dtorsin and Pu produces a strong defect
in the larval locomotor assay whereas genetic interaction of dtorsin
and ple produces a weaker but notable effect (Figure 8), is
consistent with the view that dopamine metabolism is further
compromised in these double mutants. This genetic effect parallels
our biochemical measurement of a severe reduction of GTPCH
activity but not TH activity, in dtorsin heterozygous adult flies
(Figure 9). Furthermore, western blot analyses demonstrated that
GTPCH protein levels are severely reduced in dtorsin-null
heterozygotes and hemizygotes (Figure 10). Taken together, our
Figure 8. The double heterozygous combinations for dtorsin and Punch or pale mutants show reduced mobility in third instar larvae.
A. Peristaltic frequencies were counted for the wandering stage third instar larvae of the genotype y w female (n = 31), PuZ22/+ female (n = 23),
dtorsinKO13/+ female (n = 22), and dtorsinKO13/+; PuZ22/+ female (n = 30). Results are the mean 6 S.E.M. **p,0.0001, significant difference between the
wild type females (yw, PuZ22/+, or dtorsinKO13/+) and the double heterozygous females (dtorsinKO13/+; PuZ22/+). No significant difference was observed
between the wild type females (y w) and the single heterozygous females (PuZ22/+ or dtorsinKO13/+). B. Peristaltic frequencies for the wandering stage
third instar larvae of the genotype y w female (n = 20), ple2/+ female (n = 20), dtorsinKO13/+; female (n = 31), and dtorsinKO13/+; ple2/+ female (n = 30).
Results are the mean 6 S.E.M. *p,0.05, significant difference between the wild type females (y w, ple2/+, or dtorsinKO13/+) and the double
heterozygous females (dtorsinKO13/+; ple2/+). No significant difference between the wild type females (y w) and the single heterozygous females (ple2/
+ or dtorsinKO13/+).
doi:10.1371/journal.pone.0026183.g008
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experiments suggest that presence of functional Dtorsin is required
to maintain GTPCH protein levels, indicating that, through an as
yet undetermined mechanism, dtorsin is a positive-regulator of
GTPCH protein and dopamine synthesis in Drosophila.
Interestingly, GTPCH is also critical for the activity of other
aromatic acid hydroxylases, nitric oxide synthatase [29], and
alkylglycerol monooxygenase [42]. Thus GTPCH activity is also
essential to the serotonin synthesis, suggesting that it too may be
disrupted in the dtorsin mutant. Why then did addition of serotonin
have no effect on the larval mobility in our experiments? There are
two possible explanations. The first is that the larval mobility assay
that we used may be sensitive only to a defect in the dopamine
pathway. The second is that the TH protein has a much lower
affinity for BH4 compared to tryptophan hydroxylase, the rate-
limiting enzyme in the serotonin synthesis [43], so that TH activity
is preferentially affected when the concentration of BH4 is
decreased to submillimolar levels. Further studies will be needed
to distinguish these alternative possibilities.
Figure 9. Effect of dtorsin mutation on TH activity and GTPCH activity in adult heads. A. Effect of dtorsin heterozygous mutation on TH
activity in adult heads (L-dopa nmoles/min/mg protein). The genotypes of adults were y w (n = 3 independent replications), y w dtorsinKO13/+ (n = 3
independent replications), and w dtorsinKO78/+ (n = 3 independent replications). Error bars indicate S.E.M. No significant difference between the wild
type and the dtorsin heterozygous mutant females. B. Effect of dtorsin heterozygous mutation on GTPCH activity (neopterin nmoles/min/mg protein).
The genotypes of adults were y w (n = 3 independent replications), y w dtorsinKO13/+ (n = 3 independent replications), and w dtorsinKO78/+ (n = 3
independent replications). Error bars indicate S.E.M. ** p,0.01, significant difference in dopamine levels between the wild type females and the
dtorsin heterozygous mutant females.
doi:10.1371/journal.pone.0026183.g009
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Notably, human GTPCH and TH are defective in two forms of
dopa-responsive dystonia (DYT14 and DYT5, respectively), while
torsinA is altered in DYT1 dystonia. Deficits in dopamine
neurotransmission have been implicated in all these forms of
dystonia that have a similar clinical appearance, manifesting as
early onset generalized dystonia [37,40]. DYT5 and DYT14
dystonia results from mutations in genes needed for biosynthesis of
dopamine, and symptoms can be alleviated with L-DOPA [36]. In
the case of DYT1 dystonia, the abnormality seems to involve
insufficient neurotransmission by dopamine, although levels of
dopamine are normal and, in this case, L-DOPA is not
therapeutic. In DYT1 patients, the number of dopamine receptor
binding sites in the striatum are reduced [44,45], and, in addition,
neuroleptic medications which block D2 receptors can lead to
dystonia reactions and tardive dystonia [46]. These studies support
a link between TOR1A mutation, altered dopaminergic neuro-
transmission and dystonic symptoms. This concept has been
supported in a variety of DYT1 mouse models showing that
expression of mutant torsinA causes an increase in dopamine
turnover [47], a decrease of release and uptake of dopamine in
response to amphetamine [48,49] or electrical stimulation [50],
and impairment of dopamine D2 receptor function [51]. So,
although the mechanism through which dysfunctional torsinA
leads to compromise of dopaminergic neurotransmission is not
clear, many lines of evidence supports this connection [2,40].
It is important to stress that the mutated abnormal torsinA
protein is expressed together with normal torsinA in the DYT1
animal models and DYT1 patients, while the null dtorsin fly lines
do not express any functional Dtorsin protein. Thus, the fly
mutant is fundamentally different from other DYT1 disease model
systems. The interaction between the DYT1-mutant form of the
torsinA protein (for example DGAG torsinA) and the wild type
torsinA protein could be very important for the DYT1 disease
manifestations, presumably leading to a decrease in wild type
activity. Consequently, it is essential to understand the normal
function of the torsinA protein in order to understand how
compromise of its function leads to DYT1 dystonia. The
availability of fly lines mutant for dtorsin provides the basis for
applying the powerful tools of Drosophila melanogaster genetics to
define the function(s) of the sole torsin family member in this
species, with the expectation that these activities may provide
insight into torsinA function in humans. In this regard, the ability
of the human torsinA cDNA to rescue the mobility defect of the
dtorsin null mutant demonstrates that at least the torsin function
involved in regulation of larval locomotion, which requires
expression in neurons, is well conserved between the fly and the
human. The dtorsin null fly system will therefore permit analysis of
the effects of various DYT1-causing mutations on this function,
using the biochemical, pharmacological, and genetic approaches.
Materials and Methods
Fly stocks
Flies were kept on standard medium, except for larval
locomotion analysis (see below). The y w; P{70FLP}11 P{70I-
SceI}2B Sco/CyO, S2 line for the gene targeting, GAL4 driver lines,
and the FM7i, P{w[+mC] = ActGFP}JMR3/C(1)DX, y f were
obtained from the Bloomington Stock Center. The MHC-GAL4
line was obtained from Dr. Aaron DiAntonio (Washington
University School of Medicine, MO). The DATfumin line was a
kind gift from Dr. F. Rob Jackson (Tufts University School of
Medicine, MA).
Generation of the dtorsin loss-of-function mutant lines
The ‘‘ends-out’’ targeting scheme was a modified version of a
method described previously [9,10]. The donor vector was
constructed using pw25 [10] (a gift from Dr. Kent Golic,
University of Utah, UT) in two steps. In step 1, a 4 kb genomic
fragment including the 59 portion of dtorsin was amplified from
genomic DNA (y w male) by PCR using the following primers: 59-
AGCGGCCGCGATATTATGACCCTGGCCAAGGGCTACT-
TGGAGCAGCTACCAGGACCGGGCAAGGCATCCTCCTA-
TCGCT -39 (TK4A) and 59-CGGTACCGCAAGGAAAATTC-
CGCGGTGGAATGTATAGATGGGCAAAAGCGATAGGCA-
GCATAAGACTAGA-39 (TK3A). The product was digested with
NotI and Acc65I and cloned into the NotI and Acc65I sites of pw25.
In step 2, a 3.5 kb genomic fragment of the 39 portion of dtorsin
was amplified from genomic DNA by PCR using the following
primers: 59-AGGCGCGCCGGCCATGGCCATTTACTGAG-
AAAGGACCGACCGACTCCACATTTTAATGC -39 (TK2)
and 59-CCGTACGCAATGCTGTATATATTAATCGTTTGA-
GTATAAACAAATATCACGACTTA-39 (TK1). The product
was digested with AscI and BsiWI and cloned into the AscI and
BsiWI sites of the plasmid made in step 1. Nine fly lines carrying
independent insertions of the donor construct were generated
using standard procedures. Two independent lines, B2-1 (2nd
chromosome insertion) and B7-1 (3rd chromosome insertion) were
used for further experiments. Males heterozygous for each donor
insertion were crossed to y w; P[70FLP]11 P[70I-SceI]2B Sco/S2
CyO females, and resulting larvae were heat-shocked at 38uC for
1 hour at 3 days after egg laying (AEL). The resulting unbalanced
females were mated in groups of 10 to y w; P[70FLP]11 P[70I-
SceI]2B Sco/S2 CyO males. The progeny from this cross were heat-
shocked at 3 days AEL, and 405 vials were screened for red eye
female upon eclosion. Non-mosaic, unbalanced flies were saved as
FLP-insensitive integrations. In total 14 FLP-insensitive integra-
tions were found that mapped to the X chromosome. Of those,
seven lines were hemizygous viable and seven (y w dtorsinKO13, y w
dtorsinKO14, y w dtorsinKO18, y w dtorsinKO22, y w dtorsinKO26, y w
dtorsinKO38, and w dtorsinKO78) were semi-lethal. Few male adults
survived from the seven semi-lethal lines, and no homozygous
females survived.
Southern blot analysis
Southern blots were performed using standard techniques. The
DNA was prepared from adult male survivors of y w dtorsinKO13/Y
and w dtorsinKO78/Y.
Figure 10. Effect of dtorsin mutation on TH and GTPCH protein
levels. Total adult head extracts from the wild type males (y w) (lanes 1
and 4), y w dtorsinKO13/+ females (lanes 2 and 5), or y w dtorsinKO13/Y
males (lanes 3 and 6) were analyzed by Western blots. The membrane
was probed with anti-GTPCH B/C (lanes 1–3, upper panel) and reprobed
with anti-Tubulin (lanes 1–3, lower panel). The second membrane was
probed with anti-TH (lanes 4–6, upper panel) and reprobed with anti-
Tubulin (lanes 4–6, lower panel). The location of GTPCH (43–45 kDa), TH
(58 kDa), and alpha-Tubulin (50 kDa) are indicated. Twenty mg of
proteins were loaded in each lane.
doi:10.1371/journal.pone.0026183.g010
dtorsin, a New Regulator of Dopamine Metabolism
PLoS ONE | www.plosone.org 11 October 2011 | Volume 6 | Issue 10 | e26183
Two DNA fragments were generated to the 59 and 39 adjacent
region of dtorsin coding sequence by PCR for radio labeled probes
(Probe 1 and Probe 2) (Figure S1A) and gel purified. A 514 bp
DNA fragment (Probe 1) was amplified by using the following
primers: 59- GGATCCACCCGTGGAGCCGGCGAAACTTT-
TCCGGGTGCAG -39 and 59- GGCCATGGCCATTTACT-
GAGAAAGGACCGACCGACTCCAC -39 and detected a
1.5 kb BamHI fragment in wild type (y w and w) in genomic
Southern blots (Figure S1B). A 381 bp DNA fragment (Probe 2)
was amplified by using the following primers: 59- GATTGCAG-
CACTTGCCGGCAACCGTTTCTATCGATAGTTG -39 and
59- GGATCCTGGACAGGATACGCTTGACGGATGGGCC-
TTGTTG -39 and detected a 0.5 kb BamHI fragment in wild type
(y w and w) (Figure S1B).
Genomic rescue line
A 1.9 kb genomic fragment containing dtorsin was amplified
from genomic DNA by PCR using the following primers: 59-
GCGGCCGCTTGGACCTGGACTTTTCGGGATCCTGGA-
CAGGATACG -39 and 59-GAATTCCCTCAAAGATCTGG-
GACTAGACGGAAAGCAGAGCGATTT-39. The fragment con-
tains 0.4 kb 59 non-coding region, the whole coding region of the
dtorsin gene, and 0.37 kb 39 non-coding region. The product was
digested with EcoRI and NotI and cloned into the EcoRI and NotI
sites of pCaSpeR3. Four fly lines (GDT101-1,4) carrying
independent insertions of the donor construct were generated
using standard techniques. All four lines were crossed to individual
dtorsin mutant lines.
UAS lines
A 1.2 kb dtorsin cDNA was amplified from LD20854 (LD
library, BDGP) by PCR using the following primers: 59-
CCGGAATTCCCTTGCATTTTATGATGAGCTTTCCACGC-
ATGTTA-39 and 59-GTTGCGGCCGCCATTAAAATGTGG-
AGTCGGTCGGTCCTTTCTCA-39. The product was digested
with EcoRI and NotI and cloned into the EcoRI and NotI sites of
pUAST [19].
The transgenic line B5 with UAS-dtorsin transgene on the
second chromosome was used for the rescue experiments.
A 1.0 kb human torsinA cDNA was amplified from pcDNA3-
htorA [52] by PCR using the following primers: 59-GCGGGATC-
CATTCATGAAGCTGGGCCGGGCCGTGCTGGGCCTGC-
39 and 59-CTCGAGCGGCCGCTCAATCATCGTAGTAATA-
ATCTAACTTGGTG-39. The product was digested with Acc65I
and NotI and cloned into the Acc65I and NotI sites of pUAST.
The transgenic line #8 with UAS-htorA transgene on the
second chromosome was used for the rescue experiments.
HPLC analysis
Brains of third instar larvae or heads of 48–72 hr post-eclosion
adult flies were homogenized in 0.1 M perchloric acid. Mono-
amines were separated by HPLC analysis using a CoulArray
HPLC system (model 5600A; ESA, Chelmsford, MA) and a
Synergi 4 mm Hydro-RP column (4.66150 mm; Phenomenex,
Torrance, CA) as described [21]. One hundred third instar larval
brains or 75 to 200 adult heads were extracted in 100–200 ml of
0.1 M perchloric acid. Ten microliters of each extract were
injected for each sample. Pool sizes were determined relative to
freshly prepared standards (Sigma-Aldrich). Analysis was per-
formed using ESA CoulArray software.
Tyrosine hydroxylase assay
The specific activity of tyrosine hydroxylase (TH) in tissue
extracts was determined as described previously [53] with some
modifications. Briefly, 50 fly heads were homogenized in 100 ml of
cold homogenization buffer. Homogenates were centrifuged at
9,300 x g for 10 minutes at 4uC. The protein concentration of the
supernatants was determined using BioRad protein assay reagent
(BioRad, Hercules, CA). Extracts were adjusted to equal protein
concentrations (20–30 mg/ml), and 50 ml of the extract were mixed
with 1 mM m-hydroxybenzylhydrazine dihydrochloride (NSD
1015; Sigma-Aldrich), 2 mM ferrous ammonium sulfate and 0.1%
catalase. After incubation for 5 minutes at 37uC, 200 mM L-
tyrosine and 1 mM (6R)-5,6,7,8-tetrahydro-L-biopterin (6R-BH4)
were added to the mixture and incubated for another 20 minutes
at 37uC. The reaction was terminated by adding 100 ml of stop
solution (0.1 M perchloric acid, 0.4 mM sodium metabisulphite,
and 0.1 mM EDTA) and the mixture was incubated on ice for 10
minutes. The assay mixture was centrifuged for 10 minutes at
1,000 x g at 4uC, and the supernatant was filtered through 0.2 mm
PVDF microspin filters (Analytical, Pompton Plains, NJ) and
analyzed by HPLC, as described above.
GTP cyclohydrolase activity assay
Approximately 50 heads from 48–72 h post-eclosion adults
were homogenized in 100 ml of cold 50 mM Tris, pH 8.0 solution
containing 2.5 mM EDTA and 5% sucrose. After centrifugation of
the homogenates at 9,300 x g for 10 minutes at 4uC, 5 mg of
activated charcoal was added to 100 ml supernatant with gentle
mixing to absorb eye pigment. Samples were centrifuged to
remove the charcoal, and protein concentrations were determined
using BioRad protein assay reagent. Forty-five mg of protein from
tissue extracts was mixed with GTP to a final concentration of
0.25 mM in a final volume of 70 ml. After incubation at 37uC for
1 hour, the product of the reaction, 7,8-dihydroneopterin
triphosphate, was oxidized to its fluorescent form in 30 ml of 1%
iodine and 2% potassium iodide in 1 mM HCl, and incubated for
1 hour at room temperature. The samples were then centrifuged
at 14,500 x g for 5 minutes at room temperature. The oxidation
reaction was terminated and the samples decolorized with the
addition of 15 l of 3% ascorbic acid. The samples were adjusted to
pH 8.0, and 50 ml of each sample was mixed with 2 ml of calf
intestine alkaline phosphatase, 7 ml of alkaline phosphatase buffer
(Roche Applied Science, Indianapolis, IN) and 11 ml of distilled
water. The mixtures were incubated at 37uC for 30 minutes to
dephosphorylate the neopterin triphosphate product. The super-
natant was filtered and then separated by HPLC as described
above, except that neopterin was detected by fluorescence at
excitation 360 nm/emission 465 nm, and its content was
determined by comparison to commercial neopterin (Sigma-
Aldrich) as standard using ESA CoulArray software.
Western blot analysis
For analysis of whole flies, thirty adult male flies (y w or y w
dtorsinKO13) were homogenized in 300 ml of RIPA buffer (50 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.5% deoxycholate,
0.1% SDS (sodium dodecyl sulfate)), and the homogenate was
sonicated and then clarified by a brief centrifugation (3,000 rpm
for 2 min in a microcentrifuge). For detection of protein in adult
heads, heads were removed manually from 50–60 flies of each
genotype and were homogenized either in 100 ml phosphate-
buffered saline (PBS) with Protein Inhibitor Cocktail (Roche
Applied Science, Indianapolis, IN) or in 100 ml RIPA buffer, as
above. The protein concentrations were determined with the Dc
Protein Assay Reagent (Bio-Rad, Hercules, CA). The proteins (20–
30 mg) were separated by electrophoresis in 10% SDS-polyacryl-
amide gels and transferred to nitrocellulose membranes. Mem-
branes were blocked with 5% non-fat dry milk in PBS with 0.1%
dtorsin, a New Regulator of Dopamine Metabolism
PLoS ONE | www.plosone.org 12 October 2011 | Volume 6 | Issue 10 | e26183
Tween 20 before incubation with primary antibodies. Rabbit anti-
Dtorsin antibody raised against amino acids 51–339 of Dtorsin
was a gift of Dr. Vijaya Ramesh (Massachusetts General Hospital,
Boston, MA) and used at 1:2000 dilution. GTPCH was detected
using affinity-purified polyclonal anti-GTPCH isoform B/C
antibody [54] and used at 1:1000 dilution. TH was detected
using rabbit anti-Drosophila TH [26] and was used at 1:3000
dilution. Rabbit anti-Actin (Sigma-Aldrich) and mouse anti-
Tubulin (Sigma-Aldrich) antibodies were used at 1:200 and
1:2000 dilutions. The secondary antibodies used were peroxi-
dase-conjugated anti-rabbit IgG (GE Healthcare, Piscataway, NJ
or Jackson ImmunoResearch, West Grove, PA) and peroxidase-
conjugated anti-mouse (Abcam, Cambridge, MA). Signals were
detected using Pierce ECL Western Blotting Substrate or Super-
signal West Pico Chemiluminescent Substrate (Thermo Scientific,
Rockford, IL).
Larval locomotion assay and analysis
y w dtorsinKO13 was balanced with FM7i Act-GFP. dp cu PuZ22 px sp
and ple2 were balanced with the CyO arm-GFP and TM3 Act-GFP,
respectively. GFP-negative first instar larvae were picked using a
fluorescence microscope and transferred into the vials containing
1.5 g of FORMULA4-24 instant Drosophila media (Carolina
Biological Supply Company, Burlington, NC) in 7 mls of water.
The larval locomotion assay was carried out at room
temperature. Wandering third instar larvae of a particular
genotype were picked from the vials. Male larvae were
distinguished from females by the presence of larger genital discs
as described previously [55]. A single larva was placed at the
center of 0.7% agarose in a 100 mm petri dish plate for 30 seconds
to recover from handling. The Petri dish was then placed on an
evenly illuminated fluorescent light box (TW-26; VWR Interna-
tional, Radnor, PA).
Larval locomotion was recorded for 60 seconds using a Canon
Powershot G7 attached to a Nikon SMZ800 microscope.
Peristalsis frequency was counted manually from the QuickTime
movie.
Larval movement was also recorded at 10 frames per second for
60 seconds using a digital video camera recorder (Handycam
DCR-DVD108, Sony). Video tracking was performed using
Prairie Dog, an application to trace the movement of an object
in a series of TIFF files. Prairie Dog is a new application
specifically developed by us to analyze the larval movement and is
available upon request from H. M. Some locomotion analysis
employed ICARUS software (Tracking/New User Feature) [56].
Larval head and tail locations were extracted and analyzed.
Drug feeding assay
First instar larvae of the wild type (y w) and y w dtorsinKO13 were
transferred individually to 1.0 g FORMULA4-24 instant Drosophila
media in 5 ml water or 5 ml of 20 mM dopamine-hydrochloride
(Sigma-Aldrich), 20 mM octopamine hydrochloride (Sigma-Al-
drich), or 10 mM serotonin hydrochloride (Sigma-Aldrich). Larval
locomotion assays were performed, as described above.
Antibody staining of larval brains and confocal analysis
Antibody staining of larval brains was carried out as described
[57]. Anti-dTH antibody [26] was a gift from Dr. Wendi
Neckameyer (St. Louis University, St. Louis, MO) and was used
at a 1:5000 dilution. The images were acquired by a Zeiss confocal
microscope (LSM5 Pascal) and processed with Photoshop CS4.
Multiple z-section confocal images were projected onto a single
plane with NIH Image-J software (version 1.40) by Max intensity
method.
Supporting Information
Figure S1 Isolation of dtorsin loss-of-function flies by
homologous recombination. A. Ends-out knockout targeting
scheme, illustrating how a white mini-gene was inserted into the
dtorsin genomic region, resulting in a complete deletion of the
dtorsin open reading frame while leaving the surrounding region
intact. Other genes in the dtorsin genomic region are indicated
by open boxes. Direction and location of primers that were
used to make the knockout construct are shown by arrows.
Locations of probes 1 and 2 (black boxes) and BamHI sites (B)
are indicated. B. Southern blot of BamHI digested genomic
DNA, confirming proper integration of the targeting construct.
Probe 1 detected 1.5 kb BamHI fragment in the BamHI digested
genomic DNA of the wild type (y w/Y and w/Y) males and
5.7 kb BanHI fragment in y w dtorsinKO13/Y and w dtorsinKO78/Y
males. Probe 2 detected 0.5 kb BamHI fragment in the BamHI-
digested genomic DNA of the wild type (y w/Y and w/Y) males
and 5.7 kb BanHI fragment in y w dtorsinKO13/Y and w
dtorsinKO78/Y males.
(TIF)
Figure S2 Dtorsin immunoreactivity is reduced in
dtorsin hemizygous adult extracts. A. Anti-Dtorsin antibody
recognizes a 38 kDa protein band in the wild type (y w) adult
whole body (lane 1) and adult head (lane 3) extracts that is absent
in dtorsin-null (y w dtorsinKO13) whole body (lane 2) and head (lane 4)
extracts. Thirty mg of proteins were loaded in each lane. B. Anti-
Actin antibody recognize a 42-kDa protein (Drosophila Actin) that
are present in a similar amount both in the wild type (y w) adult
whole body (lane 1) and adult head (lane 3) extracts as well as in
dtorsin-null whole body (lane 2) and head (lane 4) extracts. Thirty
mg of proteins were loaded in each lane.
(TIF)
Figure S3 dtorsin loss-of-function mutant flies exhibit
pigmentation and bristle phenotypes. A–C, Pigmentation
and bristle phenotypes of dtorsin mutants. Adult males of the
genotype y w/Y (A), y w dtorsinKO13/Y (B), y w dtorsinKO13/Y;
GDT101-2 (C). dtorsin null male dtorsinKO13 (B) had shorter, thinner
bristles with reduced pigmentation in the thorax compared to wild
type (A). Both larger bristles (macrochaetae) and smaller bristles
(microchaetae) were affected. These bristle phenotypes were
completely rescued by the introduction of 1.9 kb genomic
fragment containing the entire dtorsin gene (GDT101) (C).
(TIF)
Figure S4 Effect of dopamine feeding on the adult
pigmentation. A–D, Effect of dopamine on the pigmentation
phenotype of dtorsin mutants. Adult males of the genotype y w (A),
y w+50 mM dopamine (B), y w dtorsinKO13 (C), and y w
dtorsinKO13+50 mM dopamine (D) flies. The pictures for A–D
were taken one day after eclosion to ensure pigmentation reached
the maximum level. Dopamine was added to the fly food during
the larval period, as described in Materials and Methods.
(TIF)
Figure S5 The double heterozygous combinations for
dtorsin and DAT mutants have similar mobility com-
pared to the wild type larvae. Peristaltic frequencies for the
wandering stage third instar larvae of the genotype dtorsinKO13/+;
female (n = 7), and dtorsinKO13/+; DATfumin/+ female (n = 14) are
shown. Results are the mean 6 S.E.M. No significant difference
between the control females (dtorsinKO13/+) and the single
heterozygous females (dtorsinKO13/+; DATfumin/+).
(TIF)
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Video S1 Shown is the crawling behavior of wild type (y w) third
instar larva for 60 seconds. Wild type larvae showed smooth
peristaltic movement of 40 to 60 strides per minute.
(MP4)
Video S2 Shown is the crawling behavior of dtorsin mutant male
(y w dtorsinKO13/Y) third instar larva. dtorsin mutant larvae stopped
more frequently and changed directions of movement more often
than the wild type.
(MP4)
Table S1
(DOCX)
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